Serum Institute appeals to President Biden for Covid vaccine raw materials
In an unprecedented action, Serum Institute of India CEO Mr Adar Poonawalla has appealed directly to US President Mr Joe Biden to lift restrictions on exports of some key raw materials from the US that Serum needs to make the Covishield vaccine to prevent Covid infection.
G S Krishnan takes over as new ABLE President
“ India’s BioPharmaceutical segment has played a commendable role in the discovery and manufacturing of COVID-19 vaccine during the pandemic and we need to build on this great momentum and lead the world in playing a critical role, identifying our capabilities,” said Mr Krishnan while taking over as the new ABLE President for 2021-24.
Bharat Biotech, Biovet, Sapigen Biologix Signs Collaborative Research Agreemente with CSIR-IICT
Bharat Biotech International, Biovet, and Sapigen Biologix have signed a joint Master Collaborative Agreement (MCA) with CSIR-Indian Institute of Chemical Technology (CSIR-IICT) today, to collaborate on the development of novel platform technologies for Bio Therapeutics and vaccines to support the indigenous, affordable health care solutions for humans and animals